UCB Pharma Ltd, the manufacturer of Keppra (levetiracetam), has informed us of a change to the size of Keppra tablets. The tablets are now 15 per cent smaller than previously, which UCB hopes will make them a little easier to swallow.
UCB said: "The colours of the new tablets are the same as the older ones. The markings are the same although there is a scoring across the middle of the new tablets... This change in size does not in any way affect the way that Keppra works, including the dosage or the effectiveness.
"While the active ingredient (levetiracetam) remains unchanged, we have altered some of the inactive constituents."